Primary open-angle glaucoma (POAG) is a complex disease with unknown causes. However, in the past decade, POAG has been linked to six chromosomal regions, of which the gene MYOC encoding myocilin and the gene OPTN encoding optineurin have been identified to harbor causal mutations (disease-causing variants, DCV). POAG caused by DCV at MYOC has been termed 
INTRODUCTION
Glaucoma researchers have enjoyed success in identifying genomic variations that contribute to the pathogenesis of complex diseases. To date, six loci (GLC1A-E) (1-6) have been linked to primary open angle glaucoma (POAG) alone. Among them, two genes, MYOC encoding myocilin and OPTN encoding optineurin, have been identified to harbor causal mutations. Several other genes harboring mutations causing primary congenital glaucoma (7), autosomal dominant optic atrophy (8, 9) and other eye diseases (10) have also been mapped or identified. More than 70 mutations in the MYOC gene that encodes a protein composed of only 504 amino acids have been found to contribute to the pathogenesis of POAG. Numerous polymorphisms at MYOC, notably single nucleotide polymorphisms (SNPs), which may or may not cause glaucoma, have been reported. MYOC and its mutations have been extensively investigated in different racial/ethnical populations, in animal models, and in cell cultures. Many findings appear to be of interest not only to geneticists and ophthalmologists but also to anthropologists, sociologists and the public at large.
The discoveries of glaucoma-causing mutations are of great interest to the public, because the disease affects approximately 67 million people worldwide with about 6.7 million suffering from bilateral blindness as a result (11) . POAG accounts for half of all cases (12) .
Depending on the definition of POAG, the prevalence is 4.7% to 8.8%% in African descendants, much higher than that in Caucasians (1.1% to 2.1%) and Asians (2.6%) (13) (14) (15) . It is hoped that discovery of genes and causal mutations for POAG may help the development of more effective drugs for treatment of POAG.
One of the most interesting findings is that the prevalence of MYOC mutations is similar among Caucasian, Asian and African POAG probands (16) . This has raised a question as to whether genetic factors are responsible for the higher prevalence of POAG among African between "genetic" and "none-genetic" diseases is blurred. Nonetheless, glaucoma appears to be more of a genetic disease based on our current knowledge.
The etiology of POAG is unknown. However, it has long been recognized that patients with the disease are often found to cluster in families (32) (33) (34) . Thirty to fifty-six percent of patients with glaucoma or ocular hypertension (OHT) had a positive family history (35, 36) . First degree relatives of POAG patients or suspects are 7 to 10 times more likely to suffer from POAG compared to the general population (37, 38) . These facts suggest that genetic factors are involved in the pathogenesis of POAG, and perhaps play the central role. With the advent of modern biotechnology, mutations for many diseases have been identified and cloned. Even some good mutations for longevity (39) , high bone strength (40) and reduced risk for glaucoma (26) have been mapped (39) , cloned (40) or suggested (26) . The MYOC gene is the first discovered to be linked to POAG.
Sheffield et al. first mapped juvenile-onset open angle glaucoma (JOAG) to chromosome
1q21-q31 (1) . It was further fine-mapped to a small region (41) . The gene harboring mutations causing POAG was termed GLC1A ("GLC" stands for glaucoma, "1" for primary open-angle, and "A", the first gene discovered). Others subsequently mapped JOAG in different families to the same locus (42) (43) (44) (45) (46) (47) . Stone et al. eventually identified mutations in the MYOC gene causing JOAG (48). Later studies showed that MOYC mutations also caused adult-onset POAG (49-52).
The MYOC gene itself was independently discovered by Kubota et al. (53) and Nguyen et al. termed POAG caused by mutations at the MYOC gene "myocilin glaucoma" (55).
A wealth of data has been accumulated in the past decade, which has greatly enhanced our understanding of the nature of POAG. Meanwhile, discrepancies and confusions arise due to 7 The most common DCMs are the Gln368Stop (1.65%) and the Arg46Stop (0.99%) mutations. No mutation is found in more than 2 POAG probands in African descendants because of smaller sample size. The Arg46Stop, Arg158Gln, thr353Ile, Asp208Glu and Pro481Ser mutations initially reported as DCMs in Asian populations were later found in normal controls (26, 72) . If we include only those mutations based on the criteria of Fingert't at al. (16) , then we would have to exclude 65 POAG probands with Gln368Stop, because Gln368Stop is also found in 2 normal controls in case-control studies (23, 24) and more in family pedigree studies (49,50, 80-83). We will discuss whether these mutations are disease causing later.
Distribution of MYOC mutations
Three DCMs at MYOC (Gly252Arg, Gly367Arg and Pro370Leu) were found in Asians and Caucasians, and three (Thr293Lys, Thr377Met and Glu352Lys) in Africans and Caucasians (Table 1) . No single mutation was shared by all the three major human populations. Most DCMs at MYOC exist only in a specific racial group. For example, the most frequent mutation Gln368Stop was present only in European descendants (with one exception of an African American), and the second most frequent mutation Arg46Stop was shared only by Asian populations. Many mutations were found only in a specific region. For example, the Asn480Lys mutation was found in two geographically close European countries but not anywhere else.
Remarkably, all the 71 patients with POAG from six unrelated families from Northern France investigated by Brezin et al carried the same Asn480Lys mutation (69) . One Asn480Lys carrier from a random sample consisted of 123 unrelated Caucasian POAG patients was also from Northern France. The Gln48His mutation was found only in India (56), and the Cys433Arg mutation only in Brazil (63) . Interestingly, this Cys433Arg mutation was found in 5 of 13 white and 2 of 11 reportedly black unrelated Brazilians.
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The distribution of mutations provides information about population history, structure, movement, relation, ancestry and diversity, which is useful not only to anthropologists but also to geneticists. For example, the most common mutations, Gln368Stop and Arg46Stop, must have occurred after the divergence between Asians and Caucasians because they are not common to both populations. Distribution of genomic variations and their frequencies are the bases of the "Out of Africa" (84) and, more recently, the "Out of Ethiopia" theory (85) . Mutation distribution is also the keystone of the coalescence approach to determine the age of most recent common ancestors (86) . The "Out of Africa" theory is, in turn, the basis of the common disease/common variants hypothesis for association studies with SNPs (22). by all POAG probands with the Gln368Stop mutation suggesting a close genetic relationship among the subjects including the African American. Faucher et al. (24) showed that MYOC mutation carriers share similar haplotypes over a long stretch of DNA in five (including Gln368Stop) of the six mutations examined. These findings suggest that Gln368Stop is exclusively European in origin and is a relatively young mutation. Other mutations such as the Asn480Lys also come from one single founder (49,88). However, the Pro370Leu was more likely to have occurred twice (a recurrent mutation) (49). The few mutations shared by two major human populations are likely to have arisen from independent mutation events or gene flow because they are extremely rare in either population.
The Overall Allele Frequency of MYOC Mutations in the General Populations
Fingert et al. reported two MYOC mutation carriers in 505 Caucasian subjects from the general population, and 0 in 50 subjects from the African American general population. The number of MYOC mutation carriers was too small to estimate the allele frequency in the general populations. Therefore, we estimate below the overall frequency (f) of MYOC mutations with an average penetrance k in the general population based on the overall allele frequency (f G ) of MYOC mutations in the probands with POAG, and the known prevalence (p) of POAG.
The constant c accounts for possible imprecision in estimating p, f G or k. Since f G is similar among the three major human populations and p is about 4-fold greater in African descendants than in Caucasians, f is about 4-fold greater in African descendants if k is similar.
Let the lowest average of k (= 0.5 based on Table 5 ) for Gln368stop represent k of all DCMs at MYOC in the Caucasian population, and k = 1 in African descendants, then f is still 2-fold greater in African descendants than in Caucasians. We conclude that the higher frequency of MYOC mutations in the general population of African descendants is in part responsible for its higher prevalence of POAG. Further investigations on penetrance levels of MYOC mutations in
Africans as well as in other populations are crucial for a more accurate estimate of f.
MUTATION OR POLYMORPHISM?
In the literature, when a variant was found only in subjects with POAG, it was reported as a mutation. When it was also found in normal controls it was called (or suspected as) a Mutation is a process that changes chromosomal DNA sequence. The variant created by mutation is often called a mutation or a mutant as opposed to the wild type. When the frequency of a mutant(s) approaches that of the wild type, these alternative forms (mutants and the wild type) are often called a polymorphism. These are concepts in terms of frequency rather than function. However, historically a polymorphism was often thought of as a "normal" genomic variation, while a mutation was often associated with a disease in one's mind. In fact, a rare variant (i.e., a mutation) may not necessarily cause any diseases, while a common variant of a polymorphism associated with a disease in assoc iation studies is either disease causing or is in linkage disequilibrium with a disease-causing variant (27) . Polymorphism is created by the act of mutation (89) . Every nucleotide in the human genome was once a mutation since the very first DNA molecule had emerged on Earth. For example, the mutant ε4 allele in the apolipoprotein E gene (APOE) associated with Alzheimer's disease used to be the wild type, while ε1, ε2 and ε3
were mutations some 200,000 years ago (92). Alward et al. (61) recently used the term "diseasecausing variations (DCV)" instead of mutations, which avoids confusion.
Because of its nature (incomplete penetrance, polygenic inheritance, etc.), a DCV for complex diseases cannot be defined as a variant that is present only in cases but not in controls.
It is often determined statistically by comparing the frequencies of the mutant in question in
A more sensitive approach is to compare the absolute risk (m) for mutant carriers vs. the absolute risk (w) for wild -type carriers to develop POAG in familial studies, where m is the ratio of the number of mutant carriers with POAG to the total number of mutant carriers. Another advantage is that mutant carriers are more readily available in families with the mutant than in random samples. Since wild-type carriers with POAG are rarely observed in familial studies with a few exceptions (25), we may derive w from the general population:
where p is disease prevalence in the general population. If
Since p of POAG is small (0.02 in Caucasians, 0.026 in Asians and 0.08 in Africans) A variant conveying significant risk for a disease is often called a risk allele, a risk factor, or a susceptibility gene. In many cases a risk allele is irrelevant to the pathogenesis of a disease, because it may be in linkage disequilibrium with a DCV. However, since MYOC is well established to harbor DCV, it is unlikely that POAG in these families is caused by a DCV in linkage disequilibrium with Gln368Stop or Arg46Stop. That is, Gln368Stop and possibly Arg46Stop are DCV.
INCOMPLETE PENETRANCE
Very often, a DCV can cause the disease to some but not all individuals. Some normal DCV carriers may never develop the disease later in life. This phenomenon is called incomplete penetrance, which is expressed as the ratio of the number of DCV carriers with the disease to the total number of DCV carriers. In linkage analysis, penetrance is routinely estimated for a better LOD score. We list published penetrance estimates for different MYOC mutations in Table 5 .
The penetrances of DCVs at MYOC are age-dependent. All DCVs at MYOC have incomplete penetrance at age 30. Thr377Met has the highest penetrance, 88% at 30 years of age (90) followed by Cys433Arg (91) . Gln368STOP has the lowest. The underlying mechanisms for incomplete or complete penetrance are not well understood. Several lines of evidence suggest that increase in penetrance with age may be related to accumulation of environmental exposure with age, age-related gene expression, and gene by gene and/or gene by environment interaction.
GENE BY GENE AND GENE BY ENVIRONMENT INTERACTIONS
In Although six loci have so far been linked to POAG, the likelihood for simultaneous presence of any two DCVs at these loci in one POAG patient is very low. However, some common variants with functional significance have more chance to interact with a major DCV or with many other common variants to cause the disease, although they themselves alone may be neither sufficient nor necessary to cause POAG. Morton termed such more frequent variants with small effect "polygenes" (94) . A common allele at the APOE gene is reported to interact with an SNP in the MYOC promoter, increasing intra ocular pressure (IOP) (95) . Such an interaction might be one of the mechanisms for the occurrence of OHT.
Yoon et al. reported that a homozygote with the Arg46Stop mutation had POAG but heterozygotes did not, suggesting autosomal recessive inheritance (70) . However, Pang et al.
reported that a case of a 77-year old woman homozygous for the Arg46Stop mutation had no POAG, while a heterozygote suffered from POAG (26) . One of the explanations for these findings is that this particular variant may require unknown necessary mutations or genetic backgrounds (polygenic inheritance) or certain environmental exposure for its expression of the disease phenotype. POAG appears to be more complex than complex traits defined (27) (27) unless data are analyzed sep arately in different races.
One may also reduce the interference of certain factors statistically. In the studies of Polansky et al. (101) , many risk factors including age, family history, initial drug and surgical treatments, diabetes, gender, myopia, and initial disease severity were included in their analysis of association between MYOC.mt1 and POAG. They adjusted IOP and visual field for all these factors, reducing interference of these factors. Though a better way is to investigate subjects of the same age, sex, race and treatment (or without it), such "ideal subjects" are hard to find.
Nonetheless, once an association is found it needs to be tested in multiple samples (107) . So does the association between MYOC.mt1 and IOP and visual field.
Although six loci have been mapped, they may account for only a small fraction of glaucoma cases. Many may suffer from glaucoma as the results of interaction among polygenes or their interaction with environmental factors and/or with major genes. Thus, it is very important to identify polygenes by association studies (94) . However, because of inconsistency in results due to different designs, a journal sets criteria for a rapid rejection of association studies on complex traits (106) . While recognizing the validity of editorial scrutiny, researchers appeal for freedom of association so that results from association studies of high quality can be published (109) .
PLEIOTROPIC EFFECTS
The same mutation may cause different diseases. Sometimes, it may be deleterious to one disease and beneficial (protective) to another. This phenomenon is called pleiotropic effect.
The association of ε4 with both normal tension glaucoma (103) Gln368Stop has the highest frequency among MYOC mutations. In addition to the relatively low penetrance level (which increases fitness), one may speculate that this mutation might have some advantages for survival, similar to mutations for sickle cell anemia (111) and cystic fibrosis (30) . Identification of other effects of MYOC mutations will depend on further investigations at molecular as well as clinical levels.
ISOLATED POPULATIONS
Genetic studies in isolated populations (e.g., Finland) have several advantages such as the relatively high degree of genetic homogeneity (112) . Mutations in isolated populations tend to have a single or few founder(s), reducing genetic heterogeneity. For this reason, many diseasecausing mutations were first discovered in the Finnish population (113) . In addition to the Finnish, Old Order Amish, Hutterites, Sardinian and Jewish communities (114) , multiple genetic isolates exist in India (115) and China. The distribution of MYOC mutations suggests different degrees of isolation among human populations that are not traditionally considered as isolated populations. Because of the relative isolation and inbreeding, homozygotes of the Arg46Stop mutation were identified in Asian populations (26, 70, 93) . Such relatively isolated populations may also provide opportunity for genetic research of glaucoma.
THE COMMON DISEASE-COMMON VARIANTS HYPTHESIS
It was hypothesized several years ago that a common disease is caused by one or few common variants (116, 117) , which is called the Common Disease/Common Variants hypothesis (22) . The basis is the "Out of Africa" theory (22) . All modern humans are descendants of about 10,000 (effect size) founders (118,119) 100,000 to 160,000 years ago (84, 85) . The term "common" implies that the disease is both prevalent and widespread (22) . Mutations for common diseases are likely to have arisen before the divergence of peoples because the diseases are now widespread globally (22) . Pritchard (120) proposed that rare mutations at many loci might explain the high prevalence of common diseases. Results from studies on MYOC mutations show that a great number of rare mutations contribute to a relatively common disease, POAG. Many common variants (e.g., SNPs) are also associated with POAG (95, (99) (100) (101) (102) (103) (104) (105) and with morecommon diseases such as hypertension and Alzheimer's disease (22, 110) . Some of the SNPs may be causal. Thus, many common and/or many rare variants in interaction among themselves and with environmental factors provide a better explanation for the high prevalence of common diseases.
In this context, if one can demonstrate that a common variant (e.g., SNP) is associated with a disease in the three major human populations, then the common variant and the putative DCV must have been in linkage disequilibrium before the divergence of peoples 100,000 to 160,000 years ago. An association detected in the modern days implies that recombination events in 5,000 to 8,000 meioses (assuming 20 years per generation) have not separated the common variant and the putative DCV on the same ancestral chromosome sufficiently for them to reach equilibrium. This further implies that the two loci must be very closely linked (no more than 330 kb) (121) (122) . Therefore, association studies in three major human populations are capable of mapping DCV loci responsible for common and complex diseases to a small region (<0.3 cM and, in some case, < 0.03 cM) (122) . If SNPs at MYOC and other loci (99) (100) (101) (102) (103) (104) (105) are associated with POAG in the three major human populations independently, then DCVs are within these candidate genes rather than in genes at a distance.
PHENOTYPE DEFINITION
Geneticists are powerless without sufficient knowledge of clinical aspects of the disease of interest, especially in phenotype definition (123, 124 some genes harboring DCV are "mapped" by clinical diagnosis (126) .
MOLECULAR AND CELLULAR MECHANISMS
Morissette (127) The exact mechanisms whereby MYOC mutations cause POAG will rely on further investigation of signaling pathways of the MYOC gene.
RACE, ETHNICITY AND POAG
Diversity and polymorphisms are a great asset to the human population. A polymorphism with functional significance may be deleterious or beneficial depending on the historical clock, environment and individuals. Without diversity, the whole European population, rather than one third of it, might have been wiped out by "The Black Death" (The Plague). Diversity and polymorphism are also important in genetic studies such as admixture mapping (87), avoidance of spurious association (27) , determination of the age of most recent common ancestors (86) and fine mapping of susceptibility genes (121, 122 Gln368stop  0  27  50  73  82  Gln368stop  0  72  82  83  Thr377Met  88  90  Cys433Arg  40  75  100  91  Asn480Lys  45  75  85  98  100  69 
